Copyright
©The Author(s) 2017.
World J Hepatol. Sep 8, 2017; 9(25): 1073-1080
Published online Sep 8, 2017. doi: 10.4254/wjh.v9.i25.1073
Published online Sep 8, 2017. doi: 10.4254/wjh.v9.i25.1073
Antibody | Fluorochrome | Clone | Provider |
All panels | |||
Anti-CD3 | APC/Cy7 | SK7 | BioLegend |
Anti-CD56 | PE/Cy5 | 679.1Mc7 | Beckman Coulter |
Panel 1 | |||
Anti-CD57 | APC | HNK-1 | BioLegend |
Anti-CD25 | PE | BC96 | BioLegend |
Anti-CD69 | FITC | FN50 | BioLegend |
Panel 2 | |||
Anti-NKp30 | PE | P30-15 | Biolegend |
Anti-NKp46 | PE/Cy7 | 9E2 | Biolegend |
Anti-NKG2D | APC | 1D11 | Biolegend |
Anti-DNAM | FITC | TX25 | Biolegend |
Panel 3 | |||
Anti-CD62L | PE/Cy7 | DREG-56 | Biolegend |
Anti-CCR7 | PE | G043H7 | Biolegend |
Panel 4 | |||
Anti-TRAIL | PE | S35-934 | BD Bioscience |
Panel 5 | |||
Anti-FasL | PE | NOK-1 | Biolegend |
Anti CD94 | FITC | DX22 | Biolegend |
- Citation: Laufer N, Ojeda D, Polo ML, Martinez A, Pérez H, Turk G, Cahn P, Zwirner NW, Quarleri J. CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients. World J Hepatol 2017; 9(25): 1073-1080
- URL: https://www.wjgnet.com/1948-5182/full/v9/i25/1073.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i25.1073